Outcomes of CTAK Surgery
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-85
SponsorStanford University
About this trial
Measuring quality of vision and quality of life outcomes using a validated questionnaire in participants undergoing CTAK surgery for corneal ectasia
Eligibility criteria
Qualifiers
Corneal Ectasia and Keratoconus
Disqualifiers
Excessively thin cornea
Significant corneal scarring
Trial design
Treatments tested in this trial
- Questionnaire and Physical Exam
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov